Streetbeat News

Equity Actions

RIOT

Riot Platforms (NASDAQ:RIOT), a vertically integrated Bitcoin mining company, has received mixed analyst ratings over the past quarter, with 2 bullish and 4 somewhat bullish ratings. The average 12-month price target is $19.18, up from the previous $18.75. Analysts from firms like Cantor Fitzgerald, Roth MKM, HC Wainwright & Co., and Bernstein have maintained or raised their price targets, reflecting a positive outlook on the company's performance. Despite a strong market capitalization and exceptional ROE, Riot Platforms faces challenges with a net margin of -87.35% and an ROA of -3.22%, indicating profitability issues.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 2:01 pm

KKR

KKR & Co (NYSE:KKR) has received varied analyst ratings over the last quarter, with an average 12-month price target of $85.62, reflecting a 10.12% increase from the previous target. Analysts from firms like Wells Fargo, Keefe, Bruyette & Woods, and Morgan Stanley have raised their price targets, indicating a positive outlook on the company's performance. KKR is a major alternative asset manager with significant AUM and has shown strong financial health with high revenue growth and net margin, although its ROA and debt-to-equity ratio raise some concerns.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 2:00 pm

ORIC

ORIC Pharmaceuticals has secured a $125M private placement, issuing approximately 12.5M shares at $10.00 each. The funding involves new and existing investors such as Viking Global Investors, Commodore Capital, Frazier Life Sciences, Venrock Healthcare Capital Partners, NEA, and Nextech. This capital is expected to support ORIC's operations until late 2026.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:34 pm

THM

International Tower Hill Mines Ltd. (THM) has completed a $2.5M non-brokered private placement, issuing 3,807,911 common shares at $0.664 each to existing major shareholders including Paulson & Co. Inc., Sprott Asset Management USA, Inc., and Kopernik Global Investors, LLC. The proceeds will be used for general working capital purposes. The shares are subject to a hold period in Canada and resale restrictions in the U.S. The transaction is considered a related party transaction, with exemptions from certain requirements.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:14 pm

FELE

Franklin Electric Co., Inc. (NASDAQ:FELE) has raised its quarterly cash dividend from $0.2250 to $0.25 per share, marking the 32nd consecutive year of dividend increases. The new dividend is payable on February 15, 2024, to shareholders of record as of February 1, 2024. The increase reflects an 11 percent rise from the previous dividend and demonstrates the company's commitment to shareholder returns and confidence in its business outlook.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:10 pm

ACAB

Abpro has filed a registration statement on Form S-4 related to its business combination agreement with Atlantic Coastal Acquisition Corp. II. The merged entity will be called 'Abpro Corporation' and will trade under the ticker 'ABP'. The pre-money equity valuation of the combined company is set at $500 million.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:05 pm

CALC

CalciMedica, Inc. (NASDAQ:CALC) announced a private placement to raise up to approximately $55 million, including $20.4 million in initial funding and potential additional funding of approximately $34.2 million through warrant exercises. The proceeds will fund Phase 2 clinical trials for Auxora in acute pancreatitis (AP) and acute kidney injury (AKI), with the potential to cover subsequent pivotal trials. The private placement includes participation from new and existing healthcare investors and is expected to close in two stages, with the first on January 23, 2024, and the second on February 5, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:02 pm

SPWR

SunPower (NASDAQ:SPWR) has received mixed analyst ratings over the past three months, with a shift towards a more bearish outlook in the last 30 days. The average 12-month price target for SPWR has been lowered by 30.23% to $4.5, with a high estimate of $6.00 and a low of $2.50. Analysts from firms including Goldman Sachs, Susquehanna, Wells Fargo, and others have adjusted their ratings and price targets, reflecting changes in market dynamics and company performance. SunPower's financials show a revenue decline of -9.59% for the quarter ending September 30, 2023, a net margin of -8.68%, an ROE of -8.31%, and an ROA of -2.47%, with a debt-to-equity ratio of 0.86.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 1:00 pm

ZJYL

Jin Medical International (NYSE:ZJYL) has seen a 16.84% increase in short interest since the last report, with 64 thousand shares sold short, representing 3.47% of its float. The short interest is below the peer group average of 8.78%. While an increase in short interest can indicate bearish sentiment, it does not necessarily predict a near-term price drop.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 1:00 pm

OGN

Organon (NYSE:OGN) has seen a 5.82% increase in short interest since its last report, with 19.12 million shares sold short, representing 8.54% of its float. It would take about 5 days to cover all short positions. While an increase in short interest can indicate bearish sentiment, it doesn't necessarily predict a price drop. Organon's short interest is higher than its peer group average of 3.56%.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 1:00 pm